Answers are grounded in this paper and cite their sources.
Response rates of approved systemic therapies for cutaneous T-cell lymphoma (CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment patterns and response rates of extracorporeal photopheresis (ECP) in CTCL patients.
No takes yet. Share an insight, caveat, or question.
Girardi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: